Kite Pharma's Yescarta found to infringe Sloan Kettering, Juno Therapeutics patent Federal Circuit questions whether patent sufficiently described invention (Reuters) - A panel of judges at the U.S.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback